Goldman Sachs analyst Lisa Deng initiated coverage of Sigma Healthcare (SIGGF) with a Neutral rating and A$2.70 price target The firm views Sigma as a vertically integrated retail pharmacy leader with scaled cost and franchise advantages.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SIGGF:
- Sigma Healthcare Announces Strategic Merger to Enhance Growth
- Sigma Healthcare Ltd Announces Quotation of New Securities on ASX
- State Street Corporation Reduces Holdings in Sigma Healthcare
- Sigma Healthcare Ltd Announces Quotation of New Securities
- Sigma Healthcare Announces Director’s Securities Restructuring